Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Advanced Alveolar Soft Part Sarcoma · Advanced Soft Tissue Sarcoma · Metastatic Alveolar Soft Part Sarcoma · Refractory Alveolar Soft Part Sarcoma · Unresectable Alveolar Soft Part Sarcoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Keck Medicine of USC Koreatown, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 213-388-0908
    Contact: Principal Investigator (Mark Agulnik)
  • Los Angeles General Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · uscnorrisinfo@med.usc.edu · 323-865-0451
    Contact: Principal Investigator (Mark Agulnik)
  • USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · 323-865-0451
    Contact: Principal Investigator (Mark Agulnik)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Philippos Apolinario Costa)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Philippos Apolinario Costa)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Philippos Apolinario Costa)
  • MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States

  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 800-411-1222
    Contact: Principal Investigator (A P. Chen)
  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (David A. Liebner)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Minh Phan)
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 412-647-8073
    Contact: Principal Investigator (Melissa A. Burgess)
  • UT MD Anderson Cancer Center, Houston, Texas, United States

מובילי המחקר
  • A P Chen

    Principal Investigator

    National Cancer Institute LAO